findmyKOL
Clinical trialNCT00557206TerminatedPhase 2Interventional

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

SponsorMinneapolis Veterans Affairs Medical CenterEnrollment35Head and Neck NeoplasmsNeoplasms
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Patient receiving oxaliplatin and docetaxel will have longer progression free survival than those patients receiving standard care.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Va Medical Center

    Minneapolis, Minnesota, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Oxaliplatin and Docetaxel
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2005
Primary completion
30 Nov 2009
Completion
30 Nov 2009
Last update posted
5 Nov 2013
Registered enrollment
35
Registry id
NCT00557206
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.